Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2025-10-07 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended 30th September 2025. It is a compliance certificate issued by the Registrar & Share Transfer Agent confirming no requests for dematerialisation/rematerialization of shares were received during the quarter. The document is short (2566 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2025-10-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter from Innova Captab Limited addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window for insiders due to the upcoming declaration of unaudited financial results for the quarter and half year ended 30th September 2025. It references regulatory compliance with SEBI (Prohibition of Insider Trading) Regulations and mentions the timing of the board meeting to approve the results will be informed later. The document does not contain any financial data or results itself, nor does it present a report. It is an announcement related to trading restrictions ahead of financial results disclosure. Given the short length (1813 characters) and the nature of the content, this is an announcement related to trading window closure, which is a regulatory filing type but does not fit into other specific categories. Therefore, the best classification is Regulatory Filings (RNS).
2025-09-26 English
Credit Rating- Revision
Regulatory Filings Classification · 95% confidence The document is a formal communication from Innova Captab Limited to stock exchanges regarding a revision in credit rating by CARE Ratings Limited. It includes detailed information about the credit rating reaffirmation and outlook revision for the company's bank facilities, along with annexures detailing the rated facilities. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content is focused on credit rating updates and related disclosures rather than financial results, management changes, or other report types. It is not an annual or interim financial report, earnings release, or management discussion. The document is a regulatory announcement about credit rating changes, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure under SEBI regulations and does not constitute a financial report or audit report itself.
2025-09-16 English
Agreements
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It details the company's entry into a purchase agreement for land property to support business expansion. The document includes specifics about the agreement, parties involved, consideration, and related disclosures. It is addressed to stock exchanges and is a formal announcement of a material event (purchase agreement) rather than a financial report or detailed analysis. There are no financial statements or earnings data, nor is it a report publication announcement. This fits the category of Capital/Financing Update (CAP), as it relates to company financing activities and capital asset acquisition.
2025-08-21 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It informs about the successful completion of an inspection by the UK Medicines and Healthcare products Regulatory Agency (UK-MHRA) with no critical or major observations. The document is an intimation or announcement of an event related to regulatory compliance and inspection results, not a full report or detailed financial disclosure. The length is short (1858 characters), and it serves as a notification rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Innova Captab Limited on August 8, 2025, discussing the financial and operational performance for Q1 FY '26. It includes management commentary, financial highlights, business segment updates, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings call, which is a full text record of the call including Q&A. This matches the definition of a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive financial discussion, not just a brief announcement or summary, so it is not an Earnings Release (ER) or Report Publication Announcement (RPA). Therefore, the correct classification is Call Transcript (CT).
2025-08-13 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.